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Abstract
Background Titin is an elastic sarcomeric ﬁlament that has been proposed to play a key role in mechanosensing and
trophicity of muscle. However, evidence for this proposal is scarce due to the lack of appropriate experimental models to
directly test the role of titin in mechanosensing.
Methods We used unilateral diaphragm denervation (UDD) in mice, an in vivo model in which the denervated
hemidiaphragm is passively stretched by the contralateral, innervated hemidiaphragm and hypertrophy rapidly occurs.
Results In wildtype mice, the denervated hemidiaphragm mass increased 48 ± 3% after 6 days of UDD, due to the addition of
both sarcomeres in series and in parallel. To test whether titin stiffness modulates the hypertrophy response, RBM20ΔRRM and
TtnΔIAjxn mouse models were used, with decreased and increased titin stiffness, respectively. RBM20ΔRRM mice (reduced stiff-
ness) showed a 20 ± 6% attenuated hypertrophy response, whereas the TtnΔIAjxn mice (increased stiffness) showed an 18 ± 8%
exaggerated response after UDD. Thus, muscle hypertrophy scales with titin stiffness. Protein expression analysis revealed that
titin-binding proteins implicated previously in muscle trophicity were induced during UDD, MARP1 & 2, FHL1, and MuRF1.
Conclusions Titin functions as a mechanosensor that regulates muscle trophicity.
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Introduction
Muscle is an exquisitely ﬁne-tuned biological machine that in
response to increased mechanical load increases in size, i.e.
muscle cells hypertrophy. The underlying mechanism has
been extensively studied in contracting muscles, and
calcium-dependent activation of the calmodulin/calcineurin
pathway has been identiﬁed as an important mediator of hy-
pertrophy.1,2 Whether calcium-independent mechanisms
play a role in muscle hypertrophy is poorly understood. Such
mechanisms might involve mechanosensory proteins, of
which the giant protein titin is an attractive candidate be-
cause it forms a continuous ﬁlament along the myoﬁbril
and contains elastic segments that have been proposed to
sense muscle stretch.3–5 Titin-based mechanosensing might
involve titin-binding proteins that form several signalling
‘hubs’ along the titin molecule. In line with a mechanosensing
role for titin, disruption of two of these hubs depresses mus-
cle gene expression.3,4 Furthermore, decreasing titin stiffness
in the heart blunts hypertrophy development during mechan-
ical overload6 and increasing titin’s stiffness has the opposite
effect,7,8 processes that presumably involve titin-binding pro-
teins (e.g. FHL1/2,5 MARP1–39–12 and CAPN313,14). However,
the results of these studies are confounded by the fact that
not only was titin-based stiffness altered, so was active force
generation,15–17 which itself modulates muscle growth. Thus,
the role of titin-based mechanosensing in muscle hypertro-
phy is speculative, due to the lack of appropriate experimen-
tal approaches to directly test this role.
The goal of the present study was to establish whether
titin-based mechanosensing per se affects muscle hypertro-
phy. To this end, we turned to unilateral diaphragm
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denervation (UDD) which induces a transient but strong
hypertrophy response in the denervated, inactive
hemidiaphragm.18,19 This makes UDD ideal for directly testing
the role of titin-based mechanosensing in muscle hypertro-
phy. UDD was applied in two mouse models in which titin
stiffness is genetically altered: the RBM20ΔRRM model. which
disables Rbm20 splicing activity of titin RNA, resulting in
more compliant titin molecules, and the TtnΔIAjxn model
which deletes a small portion of titin, resulting in stiffer titin
molecules. We hypothesized that (1) UDD-associated hyper-
trophy of the denervated hemidiaphragm is caused by cyclic
stretch imposed by the contracting contralateral
hemidiaphragm, and (2) the level of hypertrophy depends
on the stiffness of titin, with high stiffness resulting in an ex-
aggerated hypertrophy response and low stiffness resulting in
an attenuated response. The ﬁndings establish UDD as a
model to study passive stretch-induced hypertrophy and sup-
port that titin functions as a mechanosensor that modulates
muscle hypertrophy.
Methods
Mouse models and unilateral diaphragm
denervation
Both RBM20ΔRRM and TtnΔIAjxn mouse models have previ-
ously been described.8,20 Brieﬂy, the RBM20ΔRRM model de-
letes the RNA recognition motif (exons 6 & 7) of the Rbm20
gene, disabling its splicing function, leading to a longer more
compliant titin isoform. The TtnΔIAjxn model deletes the IA
junction (exons 251–269) of the Ttn gene, shortening the titin
protein and creating a stiffer isoform. We used 3 month
old wildtype (WT) and homozygous mice of either genotype
(referred to as Δ) on the C57BL6j background to perform
UDD surgery. Mice were anaesthetized with a
ketamine/xylazine 120/16 mg/kg, a small incision was made
in the neck area just above the clavicle. The phrenic nerve
was isolated behind the sternohyoid muscle, and a 3–4 mm
section was transected at the height of the supraclavicular
nerve branch. Mice were closed up and allowed to recover,
and were sacriﬁced 6 days after denervation for morphomet-
ric analysis and tissue harvest. All experiments were done in
accordance with the University of Arizona Institutional Ani-
mal Care and Use Committee and followed the US National
Institutes of Health Using Animals in Intramural Research
guidelines for animal use.
Diaphragm electromyography and telemetry
Two weeks prior to UDD, WT mice were anaesthetized with
1–3% isoﬂurane. An incision was made in the abdomen just
below the ribcage. The liver was gently moved aside to reveal
the diaphragm and the electrodes were glued to the right
costal diaphragm near the phrenic nerve innervation. The
electrode lead was also sutured to the ribcage to provide sta-
bility and prevent electrode interference with diaphragm
movement. The telemetry implant HD-X11 (DSI; St. Paul,
USA) was inserted subcutaneously on the back of the mouse
and tested for successful recording of EMG signal before clos-
ing up the mouse and allowing it to recover. Two weeks after
implantation a baseline measurement was taken of unre-
strained spontaneously breathing mice, before receiving
UDD or Sham surgery as described before. EMG was visual-
ized using Ponemah analysis software (DSI; St. Paul, USA).
Diaphragm echomyography
One day after UDD, mice were anesthetized with 1–3%
isoﬂurane and the abdomen was shaved for diaphragm echo
imaging. Mice were maintained at a respiration rate of 140–
200 and imaged with a Vevo 2100 Imaging System, MS550D
probe (Fujiﬁlm VisualSonics; Toronto, Canada) for murine car-
diac imaging, with a frequency of 40 MHz. The probe was put
on the abdomen of the mouse, just below the ribcage, at a
45° angle aiming under the thorax, with mild pressure to visu-
alize the diaphragm. Standard B-mode images of the dia-
phragm were obtained, using the vena cava as a reference
point to consistently image the midcostal region. Images
where subsequently analysed using Vevo Strain software
(Fujiﬁlm VisualSonics; Toronto, Canada) that measured the
strain of the diaphragm (Figure 1C). A reiterated M-mode im-
age was used to select a single respiration cycle and a 4- to 5-
point region of interest was set in the arching region (Fig-
ure 1C, dotted-green line) of the costal diaphragm dome
using free curve to measure longitudinal strain.
Whole body perfusion and sarcomere length
measurements
Mice were anaesthetised with a ketamine/xylazine solution, a
small incision was made in the neck area where the jugular
vein was cannulated and securely tied off. The diaphragm
was visualized using echomyography as previously described.
M-mode images were taken before and after perfusion to
show the position of the diaphragm at arrest. Mice were per-
fused with a solution consisting of 4% formaldehyde, with
70 U/mL of heparin in phosphate buffered saline (PBS), after
which the diaphragm was removed and stored in 4% formal-
dehyde in PBS overnight for complete ﬁxation. Diaphragm
midcostal strips were gently ﬂattened between glass slides
and sarcomere lengths were measured using a He/Ne laser
diffraction system.21,22
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Whole body (unrestrained) plethysmography
Mice were put in Buxco FinePointe whole body plethysmog-
raphy chambers (DSI; St. Paul, USA) and acclimated for a min-
imum of 2 h to allow the mice to enter a resting state before
starting respiratory measurements. Various parameters were
recorded, including respiration rate, tidal volume, and minute
volume. Data were analysed with Buxco FinePointe software.
Diaphragm ﬁbre passive tension
Diaphragm midcostal sections were skinned overnight in
solution containing relaxing solution (in mM; 20 BES, 10
EGTA, 6.56 MgCl2, 5.88 NaATP, 1 DTT, 46.35 K-propionate,
15 creatine phosphate, pH 7.0), with 1% Triton-X-100 at
4°C, and protease inhibitors (phenylmethylsulfonyl ﬂuoride
(PMSF), 0.25 mM; leupeptin, 0.04 mM; E64, 0.01 mM, at
Figure 1 (A) EMG signal from implanted telemetry device showing electrical activity in the right hemi-diaphragm pre-UDD (top) and absence of ac-
tivity post-UDD (bottom). Data are from the same mouse and conﬁrm successful denervation. Note that both before and after UDD the telemetry de-
vice recorded bleed-through EMG signal from the myocardium. (B) Diaphragm right costal weight normalized to tibia length (TL) from Sham and UDD
operated WT mice. UDD induces a strong increase in tissue mass (TM) in the right costal hemidiaphram 6 days post-UDD. (C) B-mode image from the
right hemidiaphragm, the vena cava was used as reference. The green dotted line denotes the position of strain measurement in the right costal di-
aphragm. Inset shows an abdominal view of the diaphragm and the black line the plane of B-mode imaging. (D) Strain analysis showing maximum
strain in the contracting right hemidiaphragm (top image; shortening) in Sham mice and stretching in the denervated hemidiaphragm (bottom image;
lengthening) in UDD mice. Zero percent represents length at end-expiration. (E) Maximum strain in the right hemidiaphragm before and after UDD,
indicating that after UDD the hemidiaphragm stretches by ~25% during inspiration. (F) Representative M-mode image of the right costal diaphragm
during whole body formaldehyde perfusion, showing arrest during end-expiration. (G) Sarcomere length in the perfused diaphragm ﬁbres was
~2.9 μm (middle bar), and the strain data (in e) were used to calculate end-inspiration sarcomere length before (left bar) and after UDD (right
bar). (H) Schematic representation of the length changes in the diaphragm after UDD. Bars, mean ± SEM.
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4°C), and subsequently stored in a 50% (v/v) glycerol/relax
solution at 20°. Single ﬁbres were dissected and mounted
with aluminium T-clips between a length motor (ASI 403A,
Aurora Scientiﬁc Inc., Ontario, Canada) and a force trans-
ducer element (ASI 315C-I, Aurora Scientiﬁc Inc., Ontario,
Canada) in a single ﬁbre apparatus (ASI 802D, Aurora Scien-
tiﬁc Inc., Ontario, Canada) that was mounted on the stage of
an inverted microscope. Sarcomere length was set using a
high-speed VSL camera and ASI 900B software (Aurora Sci-
entiﬁc Inc., Ontario, Canada). Passive tension was measured
using two protocols: (1). a standard stepwise stretch-hold
protocol (referred to as static stretch), and 2. a stretch-
release protocol (referred to as dynamic stretch), in which
ﬁbres were stretched 20 times from sarcomere length 2.9–
3.7 μm at a velocity of 5.56 ± 0.49 μm/s/sarcomere, consis-
tent with diaphragm stretch velocity as derived from
echomyography analyses (Figure 2A). Fibre cross-sectional
area (CSA) was determined at three points along the ﬁbre,
assuming an elliptical cross section. All experiments were
performed in relaxing solution with inhibitors. The tempera-
ture of the relaxing solution was kept constant at 20°C using
a TEC controller (ASI 825A, Aurora Scientiﬁc Inc. Ontario,
Canada). During the experiment, data were automatically
collected by a data acquisition board (sampling rate
10 kHz), ﬁgures represent data from the ascending limb of
stretch number 20.
Figure 2 (A) M-mode image of the left hemidiaphragm during normal inspiration. (B) Using the average inspiration time and the sarcomere length
change during inspiration (0.8 μm), contractile velocity of the left hemidiaphragm was determined. (C) We assumed that after UDD the contractile
velocity of the left hemidiaphragm equals the stretch velocity of the right hemidiaphragm, and used the derived value (in B) in a stretch-release pro-
tocol imposed on single diaphragm ﬁbres to mimic the kinetics of in vivo stretching of the right hemidiaphragm after UDD. Top: the length change
imposed on the muscle ﬁbre during the protocol of 20 stretches; middle: the corresponding sarcomere length change from 2.9– to 3.7 μm; bottom:
passive force generated by the muscle ﬁbres (data from the 20th cycle, to account for hysteresis, was used to determine passive tension. (D) Average
passive tension (n = 6; 20 ﬁbres) during the 20th stretch. Note that passive tension during this in vivo dynamic protocol is higher compared to that
during a static stepwise ﬁbre stretch protocol (grey curve, n = 12; 54 ﬁbres); for protocol comparison see Supporting Information, Figure S1.
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Immunohistochemistry/structured illumination
microscopy
Diaphragm midcostal sections were stretched to slack length
and embedded in Tissue-Tek O.C.T. compound (Ted Pella Inc.;
Redding, USA) and immediately frozen through 2-
methylbutane-cooled in liquid N2 and then stored at 80°C.
Tissue was sectioned into 10 μm thick sections, cross- and
longitudinal cut, on a Microm HM 550 cryostat (Thermo Sci-
entiﬁc; Waltham, USA) and placed on super frost slides. Sec-
tions were blocked with 10% goat serum in PBS and
incubated overnight with primary antibodies diluted in
blocking solution. Primary antibodies were detected with
Alexa Fluor conjugated secondary antibodies. Sections were
repeatedly washed with PBS for 20 min and incubated with
secondary antibodies at room temperature in a dark box for
1 h. Coverslips were mounted onto slides with Fluoromount
G (Thermo Scientiﬁc; Waltham, USA) and imaged promptly.
A Zeiss Axio Imager M1 microscope (Zeiss; Oberkochen,
Germany) at ×100 magniﬁcation was used to image complete
cross sections and ×640 for longitudinal sections along four
points of the ﬁbre bundles for sarcomere lengths, and
captured using a AxioCam MRc with Axiovision software
(Zeiss; Oberkochen, Germany). Images were calibrated using
a 0.01 mm stage micrometre (Edmund Optics; Barrington,
USA). For MARP1 localization we co-labelled sections with
MARP1, MyHC2x exclusion ab and DAPI (40,6-diamidino-2-
phenylindole), and used ImageJ to generate plot proﬁles.
For CSA and ﬁbre type determination we used serial cut
slides stained with three antibody combinations to cover all
myosin heavy chain (MyHC) ﬁbre types: (1) Laminin, MyHC1
and MyHC2b; (2) laminin, MyHC2x exclusion ab, pan MyHC;
(3) Laminin, MyHC2a (see Supporting Information, Table S1
for further details). MyHC2ax hybrid ﬁbres were determined
by overlaying images of slides stained with antibody combi-
nations 2 and 3. All images were analysed by subtracting
the laminin stained matrix from the MyHC stain, to demar-
cate ﬁbre edges, and using the threshold and particle
analyser functions in ImageJ, with exclusion criteria set to ex-
clude ﬁbres with a circularity of <0.5 and size smaller than
100 μm2 for MyHC1 and 150 μm2 MyHC2 ﬁbres. Longitudinal
sections from the same samples were stained for α-actinin
(see Supporting Information, Table S1) and sarcomere length
was determined ~100 μm along the ﬁbres at random loca-
tions. Sarcomere lengths were used to normalize the CSA of
the ﬁbres to a length of 2.6 μm.
For MARP1 localization, we applied a comparable protocol,
except that 4 μm thick longitudinal sections were cut.
Sections were permeabilised with 0.2% Triton X-100 in PBS
and placed on a light box to bleach autoﬂuorescence for
10 min, followed by a 1 h blocking step in 2% fetal bovine
serum in PBS. Antibodies directed against MARP1, titin’s
N2A segment and α-actinin (see Supporting Information,
Table S1) were diluted in the blocking solution and stained
at 4°C overnight. Sections were washed four times in cold
PBS and incubated for 3 h with appropriated secondary anti-
bodies (see Supporting Information, Table S1). After washes
in cold PBS, sections were covered with Vectashield Antifade
Mounting Medium (H-1000, Vector laboratories, Burlingame,
USA) and covered with precision coverslips (1.5H, thickness:
170 μm, Bioscience tools; San Diego, USA). Slides were im-
aged with a Zeiss Elyra S.1 (Zeiss; Oberkochen, Germany)
structured illumination microscope (SR-SIM), using an α-
Plan-APO 100x/1.46 Oil objective, solid-state lasers (488/
561/642 nm) and a sCMOS camera. All images were
channel-aligned using a slide with 0.2 μm T7280, TetraSpeck
Microspheres ﬂuorescent beads (Invitrogen Molecular
Probes; Eugene, USA). Images were captured with Zen 2.3
(Zeiss Microscopy; Jena, Germany) software using the same
scanning intensities for all images. Image stacks were ac-
quired with 0.101μm Z-steps, ﬁve angles and ﬁve
phases/angle for each slice and SIM processed. ImageJ was
used to derive colour plot proﬁles using an RGB proﬁler
plugin.
The number of sarcomeres in series
Diaphragm right midcostal regions were excised and ﬁxed for
24 h in 4% formaldehyde, 11 mM thymol, fortiﬁed with 15%
ethanol in distilled water. After stringent washes with distilled
water diaphragm strips were incubated in 26% HNO3 for 4 h
to dissolve the extra-cellular matrix. HNO3-treated dia-
phragm strips were washed in distilled water and stored in
50% glycerol for 7–14 days before ﬁbre bundle isolations
started.23 Small ﬁbre bundles were isolated with
microforceps and transferred to glass slides for visualization.
Fibre bundles were imaged with a Zeiss Axio Imager M1 mi-
croscope (Zeiss; Oberkochen, Germany) at ×50 magniﬁcation
for total ﬁbre length, and ×640 at four points along the ﬁbre
bundles for sarcomere length, and captured using a AxioCam
MRc with Axiovision software (Zeiss; Oberkochen, Germany).
Images were analysed using ImageJ, measuring complete
bundle length as well as determining the number of sarco-
meres using 1D plot proﬁle within a minimum of 200 μm of
the ﬁbres, to deﬁne the total number of sarcomeres in series.
SDS gel electrophoresis, western blotting, and titin
mobility gels
The ventral part of the diaphragm right costal were ﬂash-
frozen in liquid nitrogen and stored at 80°C. Tissue was
ground to a ﬁne powder using Dounce homogenizers cooled
in liquid nitrogen and acclimated to –20°C for 30 min before
continuing. Tissue powder was resuspended in a 1:1 mixture
of an 8 M urea buffer (in M; 8 urea, 2 thiourea, 0.05 Tris–HCl,
0.075 dithiothreitol, as well as 3% SDS and 0.03%
Titin-based mechanosensing modulates muscle hypertrophy 951
Journal of Cachexia, Sarcopenia and Muscle 2018; 9: 947–961
DOI: 10.1002/jcsm.12319
bromophenol blue, pH 6.8) and 50% glycerol containing pro-
tease inhibitors (in mM; 0.04 E-64, 0.16 leupeptin, and 0.2
PMSF). The solutions were mixed for 4 min, followed by 10
min of incubation at 60°C. Samples were centrifuged at
12.000 rpm and the supernatant was divided into smaller
aliquots and ﬂash frozen for storage at 80°C. SDS-agarose
(SDS-AGE) 1% were run on in a Hoefer SE600X vertical gel sys-
tem (Hoefer Inc; Holliston, USA) was used to electrophoreti-
cally separate titin from other proteins.24 Gels were run at
15 mA per gel for 3 h and 15 min, then stained using
Neuhoff’s Coomassie brilliant blue staining protocol, scanned
using a commercial scanner (Epson 800, Epson Corporation,
Long Beach CA). For titin size estimations in the mouse
models, we essentially ran the same protocol with the addi-
tion of co-migrating the samples with: human soleus N2A
(3700 kDa), human cardiac (N2B 3000 kDa, N2BA 3300 kDa)
and mouse RBM20Δ cardiac (N2BA 4000kDA, largest known
titin isoform) samples, in the same lane and using imageJ to
measure the migration distance of the reference samples
relative to MyHC. By taking the logarithm of the migration
distance of the reference samples, an exponential ﬁt could
be used to calculate the relative size of mouse wildtype, dia-
phragm RBM20ΔRRM and TtnΔIAjxn titin.
Titin binding and Z-disc associated proteins: MARP1–3,
CAPN3, MuRF1 & 2, FHL1 & 2, MYPN, CaM, Csrp3, CaN and
Ldb3, were quantiﬁed using western blot. MyHC levels were
determined from Coomassie stained initial gels to determine
equalized loading for each sample. Samples were run on 10%
acrylamide gels at 100 V for 1.5 h and subsequently trans-
ferred onto Immobilon-P PVDF 0.45 μm membranes
(Millipore, Billerica, USA) using a Trans-Blot Turbo Transfer
System (Bio-Rad, Hercules, USA) for 30 min at 1.0 A. Mem-
branes were incubated with primary antibodies (see
Supporting Information, Table S1) at 4°C overnight. IR West-
ern blots were analysed using Odyssey Infrared Imaging Sys-
tem (Li-Cor Biosciences, USA). All proteins were normalized
against GAPDH, and subsequently UDD samples were normal-
ized to Sham diaphragms to determine relative changes in
protein quantity.
Statistics
All data were analysed using Graphpad Prism software, using
unpaired t-tests (Figure 1, 2), nonlinear regression (Figures 2,
3), or 2-way ANOVA (Figures 3–5) if applicable. The signiﬁ-
cance in nonlinear regression represents the difference in
ﬁt between equations, an extra sum-of-squares F test deter-
mined whether the data sets differed from each other. The
following symbols indicate signiﬁcance in the ﬁgures:
*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 and
interaction factor from 2-way ANOVA is represented as:
#P < 0.05, ##P < 0.01, ###P < 0.001, ####P < 0.0001 vs. results
from Sham diaphragms.
Results
Unilateral diaphragm denervation induces cyclic
stretch and hypertrophy in passive muscle
To establish UDD as a model for stretch hypertrophy, we ﬁrst
corroborated previous observations that severing one (of
two) phrenic nerve leads to paralysis and hypertrophy of
the hemidiaphragm.25–28 We transected the right phrenic
nerve and using an implanted telemetry device, measured
electrical activity in the right costal before and after UDD to
conﬁrm denervation. Before denervation the telemetry de-
vice recorded a steady electromyography (EMG) signal con-
sistent with diaphragm muscle activity (Figure 1A; pre-
UDD), which disappeared after transecting the right phrenic
nerve (Figure 1A; post-UDD). To assess the effect of UDD on
muscle mass, the right costal diaphragm was dissected 6 days
after denervation (the peak of the transient hypertrophy25,27)
and we observed a signiﬁcant increase in wet tissue mass
(48.2 ± 6.6% vs. Sham) (Figure 1B). Skeletal muscle denerva-
tion is usually associated with atrophy, and we hypothesized
that the hypertrophic response of the denervated right
hemidiaphragm is caused by cyclic passive stretch imposed
by the contracting contralateral hemidiaphragm. To deter-
mine whether the denervated hemidiaphragm stretches dur-
ing inspiration, we used echomyography in combination with
strain analysis in the costal diaphragm. We observed that a
contracting costal diaphragm shortens 24.8 ± 1.2% during in-
spiration and that the denervated hemidiaphragm antagonis-
tically lengthens during inspiration by 25.4 ± 2.0% (Figure 1C–E).
Thus, UDD results in cyclic stretch of the denervated right hemi-
diaphragm and induces a marked hypertrophic response.
High passive tension in stretched diaphragm ﬁbres
during UDD
The determined strain amplitude in the denervated
hemidiaphragm suggests that passive tension development
is substantial during inspiration. To determine the effect of
diaphragm strain on passive tension development, we ﬁrst
measured the sarcomere length in diaphragm strips dissected
from mice that received whole body perfusion ﬁxation, with
the diaphragm ﬁxed at end-expiration (as determined by
echomyography; Figure 1F). Sarcomere length in the right
costal diaphragm was 2.93 ± 0.04 μm (Figure 1G). Next, we
used the end-expiration sarcomere length and the strain
measured during UDD (i.e. maximum stretch, Figure 1E) to
calculate the sarcomere length range during the respiration
cycle. Results indicate that during inspiration the non-
denervated hemidiaphragm contracts to 2.20 ± 0.04 μm
and the denervated hemidiaphragm is stretched to a sarco-
mere length of 3.68 ± 0.06 μm (Figure 1G, left and right bars,
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respectively). Figure 1H shows a schematic of the length
change of the denervated right hemi-diaphragm during
inspiration. The passive tension generated during stretch
of the denervated hemidiaphragm was measured in perme-
abilized diaphragm ﬁbres that underwent a stretch-release
protocol similar to that determined in vivo (for details, see
Methods, Figure 2 and Supporting Information, Figure S1).
This protocol was designed to mimic in vivo diaphragm kinet-
ics (stretch velocity of 5.6 μm/s, 3 ms hold, release velocity of
6.4 μm/s, 20 ms hold; based on echomyography (Figure 2A, B),
Figure 3 (A) Domain structure of titin in skeletal muscle. Immunoglobulin (Ig)-like domains in red; ﬁbronectin type III (Fn) domains in white; PEVK in
yellow; titin kinase in black; unique sequence in blue. The exons targeted for insertion in RBM20ΔRRM model (orange exons, approximation of
RBM20 splice targets; underlined blue) and deletion in the TtnΔIAjxn mouse model (underlined red). (B) These deletions result in a difference in titin
(Ttn) migration, relative to nebulin (neb) on SDS-AGE (note that Ttn
ΔIAjxn
sample was not co-migrated next to WT sample, hence the black line separa-
tion, however they were run on the same gel. For titin size estimation, see text. (C)Maximum strain in the denervated hemidiaphragm was not different
between RBM20
ΔRRM
, Ttn
ΔIAjxn
, and wt mice after UDD. (D) Similarly, respiration rate (i.E. strain rate) in the denervated hemidiaphragm was not differ-
ent between conscious RBM20ΔRRM, TtnΔIAjxn, and wt mice after UDD. Tidal and minute volume were also unaffected by the genotype, see Supporting
Information, Figure S2. (E) Passive tension, as determined by the stretch-release protocol, was signiﬁcantly lower in the RBM20ΔRRM mice (n = 4; 13
ﬁbres) and higher in the Ttn
ΔIAjxn
(n = 4; 13 ﬁbres) mice compared to WT mice (n = 6; 19 ﬁbres). (F) the increase in diaphragm right costal (denervated)
tissue mass (TM) after UDD is attenuated in the RBM20ΔRRM mice and exaggerated in the TtnΔIAjxn mice (n = Sham; UDD). Graphs represent mean ± SEM.
Titin-based mechanosensing modulates muscle hypertrophy 953
Journal of Cachexia, Sarcopenia and Muscle 2018; 9: 947–961
DOI: 10.1002/jcsm.12319
and sarcomere length change from 2.9 to 3.7 μm). Passive ten-
sion at sarcomere lengths that represent those at maximum
stretch (3.7 μm; end-inspiration) were 135.0 ± 25.8 mN/mm2
and those at end-expiration (SL 2.9 μm) 17.5 ± 7.1 mN/mm2
(Figure 2D). Thus, cyclic stretch after UDD leads to
development of high passive tension in the denervated
hemidiaphragm. Titin being an important contributor to
passive tension generation in striated muscle, and a protein
implicated in mechanosensing activity, we hypothesized that
titin-based passive tension modulates the stretch-induced
hypertrophy in the denervated hemidiaphragm after UDD.
Titin based tension modulates stretch-induced
hypertrophy
To assess whether titin-based passive tension plays a role in
passive stretch-induced hypertrophy, we used two mouse
models with changes in titin-based passive tension. First, a
model in which RBM20 splicing activity is disabled (the
RBM20ΔRRM mouse model), increasing titin isoform size by
~220 kDa (as determined by titin mobility shift in SDS-AGE
gels, Figure 3A,B). Second, a model in which titin’s IA junction
region is deleted (the TtnΔIAjxn mouse model), decreasing titin
Figure 4 (A) Fibre type composition before and after UDD. Note that UDD induces a shift toward slower ﬁbre types (WT: n = 21 mice; RBM20ΔRRM:
n = 14; TtnΔIAjxn: n = 11); (B) representative cross sections of right costal diaphragm in Sham and UDD mice. Red = ɑ-laminin, blue = ɑ-type 2x ﬁbres,
green = ɑ-type 1 & 2a ﬁbres. (C) Changes (%) in MinFeret after UDD in WT (n = 20), RBM20ΔRRM (n = 13) and TtnΔIAjxn (n = 9) mice compared to Sham
mice. Note the differential response in the two titin models. (D) Effect of UDD on the number of sarcomeres in series; top right: representative ﬁbre
segment used for assay. (E) Schematic illustration showing the nature of the diaphragm ﬁbre hypertrophy after UDD. (F) The cumulative hypertrophy
(longitudinal combined with cross-sectional hypertrophy) accounts for the mass increase observed in Figure 3F. Graphs represent mean ± SEM.
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size by ~120 kDa (Figure 3A,B). We hypothesized that an in-
crease in titin isoform size (and the concomitant reduction
in passive tension) reduces the hypertrophy response to pas-
sive stretch and, vice versa, that a decreased titin isoform size
(and the concomitant increase of passive tension) increases
the hypertrophic response.
First, we tested whether the diaphragm strain after UDD
was comparable between the two models: echomyography
analysis after UDD showed ~25% lengthening of the dener-
vated hemi-diaphragm during inspiration in both models
(Figure 3C). No differences were observed in respiratory
parameters after UDD, as measured with unrestrained whole
body plethysmography: both models showed a comparable
decrease in tidal volume, and a comparable increase in
respiratory rate (Figure 3D) and minute volume after UDD,
(Supporting Information, Figure S2). Thus, the effect of UDD
on diaphragm strain and strain rate (i.e. respiratory) was
comparable in wildtype, RBM20ΔRRM and TtnΔIAjxn mice.
To assess the effect of UDD on passive tension generation
in these models, we repeated the stretch-release protocol
and found that passive tension was lower in RBM20ΔRRM
mice and increased in the TtnΔIAjxn mice (in-line with the
larger and smaller titin isoform size, respectively), compared
to wildtype mice (Figure 3E). Importantly, these differential
changes in passive tension during stretch were associated
with differential changes in costal tissue mass after 6 days
UDD: in wildtype mice the mass increase was 48.2 ± 6.6%
in UDD vs. Sham. This hypertrophy response was attenuated
by 20% (40.5 ± 3.2% increase vs. Sham) in the RBM20ΔRRM
model, and was exaggerated by 18% in the TtnΔIAjxn model
Figure 5 (A) Left panel: Several titin-binding proteins are upregulated after UDD (grey bars; levels normalized to GAPDH levels; n = 15–18). Middle
panel: MARP1 and CAPN3 are differentially upregulated in the two titin models, with exaggerated upregulation in the RBM20ΔRRM (blue bars) and at-
tenuated upregulation in the TtnΔIAjxn model (red bars); n = 9 for the titin models. Right panel: Representative images of the corresponding western
blots. We also probed for FHL2, MuRF2 and MYPN, but these were undetectable in both Sham and UDD samples. (B) Upregulation of z-disc proteins
after UDD (left panel, grey bars; levels normalized to gapdh levels; n = 17). Note that none of these proteins was differentially upregulated in the two
titin models (middle panel). Left panel shows the corresponding western blots.
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(54.3 ± 3.6% increase vs. Sham) (Figure 3f). The denervated
right crus leaf (a region of the hemidiaphragm that has a dis-
tinctly different ﬁbre direction compared to the costal region)
showed no signs of mass increase after 6 days (Supporting
Information, Figure S3), further supporting the notion that
stretch induces mass increase, with titin being a modiﬁer in
a passive tension dependent manner.
Titin-based passive tension affects stretch-induced
hypertrophy of diaphragm ﬁbres
To assess that the tissue mass increase was due to an in-
crease in diaphragm ﬁbre size, we performed immunohisto-
chemistry on cryosections to determine ﬁbre CSA per ﬁbre
type. MinFeret measurements revealed a ﬁbre size increase
after UDD in most ﬁbre types, with the most pronounced in-
crease in type 1, 2a, and the hybrid 2a/2x ﬁbres (Figure 4A–C;
for more detail see Supporting Information, Table S2). Two-
way ANOVAs for the individual ﬁbre types revealed a signiﬁ-
cantly different response in the different genotypes, with
an attenuated increase in minFeret in diaphragm ﬁbres of
the RBM20ΔRRM mice when compared to wildtype mice,
and an exaggerated increase in the TtnΔIAjxn mice
(Figure 4C). UDD elicited a shift in ﬁbre type toward type
2a-like ﬁbres at the cost of 2x ﬁbres (Figure 4A,B). This shift
was comparable in wildtype and TtnΔIAjxn mice, but different
in RBM20ΔRRM mice which had a higher presence of type 2a
ﬁbres before UDD (Figure 4A).
The increase in ﬁbre size and the ﬁbre type shift combined
cannot fully explain the increase in tissue mass. To evaluate
whether UDD also results in longitudinal hypertrophy, we
isolated full length ﬁbre bundles (from central tendon to rib
cage) from Sham and UDD mice, and determined the number
of sarcomeres in series. This revealed that after 6 days of UDD,
the number of sarcomeres in series had increased by ~30%.
The extent of this increase was comparable between
wildtype, RBM20ΔRRM and TtnΔIAjxn mice (Figure 4D and
Supporting Information, Table S2). The combined changes in
CSA, ﬁbre type and sarcomeres in series accounts for the
increase in tissue mass after UDD (Figure 4E). Importantly,
this cumulative hypertrophic response was attenuated in
RBM20ΔRRM and exaggerated in TtnΔIAjxn compared to wildtype
mice (Figure 4F), with the differential response between
the models mainly caused by differential changes in ﬁbre CSA.
The changes in hypertrophy coincided with high upregula-
tion of both titin-binding proteins and Z-disc associated pro-
teins (Figure 5A,B, grey bars), both mechanosensors
implicated in trophic signalling. Of these proteins, only the
titin-binding proteins MARP1 (P = 0.0014) and CAPN3 auto-
lytic fragment (P = 0.0379) were differentially regulated, with
higher levels in the RBM20ΔRRM model and lower levels in the
TtnΔIAjxn model (Figure 5A, blue and red bars, respectively). Z-
disc associated proteins such as Csrp3 and CalN, although
upregulated, were insensitive to titin-based passive stiffness
(Figure 5A, blue and red bars, respectively), suggesting that
Z-disc mechanosensing operates independent of passive
tension and does not determine the extent of hypertrophy,
further supporting the concept that titin is a mechanosensor
that modulates stretch hypertrophy. To account for altered
splicing of other proteins than titin in RBM20ΔRRM mice, which
might affect hypertrophy development and confound the re-
sults, we targeted two known splice targets of RBM2029,30:
FHL1 and LDB3 (Figure 5). LDB3 isoform levels in RBM20ΔRRM
mice are not signiﬁcantly different from wild type mice in
Sham-operated mice, and also not after UDD. In Sham-
operated mice, FHL1 levels are higher in the RBM20ΔRRM mice
compared to wild type mice, however the same is true in the
TtnΔIAjxn mice, and although the relative levels of FHL1 in
UDD-operated mice are lower the total FHL1 levels do not
differ between wild type, RBM20ΔRRM and TtnΔIAjxn mice. This
suggests that the higher FHL1 levels are not related to altered
splicing by Rbm20 and that FHL1 does not directly regulate
the extent of hypertrophy development.
To evaluate the localization of MARP1, we performed
immuno-labelling on diaphragm cross sections with MARP1
antibodies. These studies revealed that in Sham-operated
mice MARP1 signal was low and nonspeciﬁc in nature, with
random distribution in the ﬁbres and non-detectable signal
in western blot (Figure 5A). Following UDD, MARP1 primarily
localizes to the sarcomere and cytosol (Figure 6A–F), with
minor signal in the nucleus (Figure 6F). To determine the
sarcomeric localization with high spatial resolution, we
applied super-resolution microscopy on longitudinal
sections and localized MARP1 to the N2A-segment of titin
(Figure 6G–P).
Discussion
In this work it was tested whether titin-based
mechanosensing modulates muscle hypertrophy. We used
unilateral diaphragm denervation, an in vivo model that in-
duces rapid, massive hypertrophy of the denervated dia-
phragm. A unique feature of UDD is that the hypertrophy
develops in the absence of calcium-cycling. This is in contrast
to limb muscle hypertrophy models, in which hypertrophy is
induced by mechanical overload and mediated by calcium-
dependent activation of the calmodulin/calcineurin path-
way.1,2 Hence, the mechanism underlying hypertrophy in
the UDD surgery model could be fundamentally different
from limb muscle models. Our results show that UDD-
induced hypertrophy is caused by cyclic stretch of the dia-
phragm and that the extent of the hypertrophy is dictated
by titin-based passive stiffness: high stiffness results in a
stronger hypertrophic response and low stiffness in an atten-
uated response. These ﬁndings support that titin is a
mechanosensing protein that modulates muscle hypertrophy.
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Muscle cyclic passive stretching and hypertrophy
UDD is known to induce a transient hypertrophy,18,19 yet, the
trigger for this hypertrophy response was unknown. We show
that this trigger is the passive, cyclic stretch of the denervated
hemidiaphragm, imposed by the contracting contralateral
diaphragm. A role for neural growth factors is unlikely as
hypertrophy did not develop following bilateral diaphragm
denervation (data not shown). Diaphragm length changes
were established by measuring the spatial movement of
echo-sensitive speckles along the costal diaphragm ﬁbres,
i.e. strain analysis (Figure 1). This measurement is indepen-
dent of diaphragm curvature, providing a non-invasive
method for measuring muscle shortening or lengthening. In
Sham-operated mice, we observed ~25% shortening of the
costal diaphragm during inspiration (Figure 1C–E), a percentage
that is consistent with recent studies on human diaphragm.31
Combining the echomyography ﬁndings with the measured
sarcomere length at end-expiration (2.9 μm; Figure 1F–H; note
that similar end-expiratory sarcomere lengths have been
reported in other mammals32,33) suggest that in diaphragm of
mice the operating sarcomere length range is ~2.2–2.9 μm
during normal breathing (Figure 1F). UDD caused stretch of
the denervated diaphragm ﬁbres during inspiration, with
sarcomere length extending by 25%, from 2.9 to 3.7 um.
Importantly, this strain in the denervated hemidiaphragm was
comparable between RBM20ΔRRM, TtnΔIAjxn and wild type mice
(Figure 3C), indicating that the ‘pulling force’ exerted by the
innervated hemidiaphragm was not affected by the changes
in titin isoform size. Thus, the differential hypertrophy response
in the mouse models is not caused by differential passive
stretch of the denervated diaphragm ﬁbres.
Static stretch of active muscle is known to induce increases
in muscle mass by increasing the number of sarcomeres in
series, i.e. longitudinal hypertrophy.34–36 The current ﬁndings
show that cyclic stretch of passive muscle is a strong stimulus
for longitudinal growth of muscle ﬁbres. This growth is ex-
pected to reduce the strain on the sarcomeres during stretch
and to restore thick-thin ﬁlament overlap. Indeed, immedi-
ately after the UDD surgery we determined that the muscle
ﬁbres contain ~3200 serially-linked sarcomeres (Supporting
Information, Table S2) that are stretched to a sarcomere
length of ~3.7 μm at end of inspiration. This corresponds to
ﬁbre a length at end of inspiration of 3200 × 3.7 μm, or
11840 μm. Our ﬁndings show that after 6 days of UDD, the
number of sarcomeres has increased to ~4100. Assuming a
similar total ﬁbre length, this corresponds to an end-
inspiration sarcomere length of 11840/4100, or 2.9 μm, i.e.
at end-inspiration the denervated sarcomere length is now
the same as that of the innervated diaphragm. This adapta-
tion in sarcomere length also explains the transient nature
of hypertrophy: as sarcomere length normalizes due to the
Figure 6 Cross sections stained for MARP1 (red), BF-35 (green; MyHC2x exclusion) and DAPI (blue), showing absence of MARP1 signal in Sham-oper-
ated mice (A; n = 4) and myoﬁlament/cytosol localization in mice after UDD (B; n = 4). No MARP1 nuclear localization was observed in Sham-operated
mice (C) and in mice after UDD (D); plot proﬁles of representative images illustrate the absence of MARP1 in nuclei in Sham-operated mice (E) and in
mice after UDD (F). Using SIM, we determined that after UDD MARP1 (red) localizes to the N2A-segment of titin (blue), visualized as doublets ﬂanking
the z-disc (α-actinin; green). Representative images of Sham-operated mice (G–J) and mice after UDD (I-O), with plot proﬁles [(K) and (P)] showing the
co-localization of MARP1 and N2A (n = 3).
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addition of sarcomeres in series, the hypertrophic stimulus
diminishes. Interestingly, the increased muscle mass was
not only caused by addition of sarcomeres in series but also
by addition of sarcomeres in parallel (cross-sectional hyper-
trophy). The increase in cross-sectional area is another mech-
anism to reduce sarcomere strain by increasing the resisting
force of the muscle ﬁbre during stretch.
Titin-based mechanosensing modulates
hypertrophy
Our ﬁndings show that titin-based passive tension modulates
the hypertrophy response during passive muscle stretch
(Figures 3F and 4). There are multiple previous studies that
support titin mechanosensing activity through the elastic
cardiac-speciﬁc N2B element, where hypertrophy seems to
be regulated through the four-and-a-half LIM domains
proteins (FHL) and the mitogen-activated protein kinases
(MAPK).4,5,37,38 Also deletion of the serine/threonine kinase
(TK) domain of titin results in hypertrophy in the heart39 and
deletion of part of the skeletal muscle elastic N2A domain re-
sults in severe dystrophy,40 highlighting the importance of the
various titin signalling hubs in muscle growth. However, these
studies were performed in intact, contracting muscle. Conse-
quently, the results might be confounded by the presence of
calcium cycling: calcium binds to the PEVK spring-domain of
titin, changing its stiffness,15–17 and titin-based stiffness mod-
ulates contractility20,41–44 which in turn might affect muscle
growth. The importance of the current ﬁndings is that they
show that the effects of titin-based mechanosensing occur in-
dependent of contractile activity, and can be ascribed to titin’s
elastic properties. The differential hypertrophy response in
the two models with altered titin stiffness was not due to
changes in muscle strain (Figure 3C) or in respiration fre-
quency (Figure 3D), showing that titin stiffness directly
modulates the hypertrophy response at the sarcomere level.
Interestingly, titin stiffness modulates cross-sectional hyper-
trophy of muscle ﬁbres, more than longitudinal hypertrophy
(Figure 4). We speculate that the longitudinal hypertrophy,
presumably driven by the need to maintain optimal thick-thin
ﬁlament overlap, requires a second sensor in addition to titin.
The z-disc might be such a sensor, as multiple of its signalling
proteins (Figure 5B) are upregulated in response to UDD, albeit
independent of titin stiffness. In particular, cysteine and
glycine-rich protein 3 (Csrp3; muscle LIM protein; MLP) showed
strong upregulation and has been linked to both z-disc- and
costamere-based hypertrophy signalling.45 Another potential
sensor might be the m-band, where both the titin kinase
domain and obscurin form a mechanosensing complex.3,46
We observed upregulation of m-line proteins CAPN3 and
MuRF1 (Figure 5A), with the latter regulated independent of
titin stiffness. Future studies are needed to resolve the intrica-
cies of longitudinal hypertrophy following passive stretch.
To study how titin stiffness modulates cross-sectional hy-
pertrophy during cyclic, passive muscle stretch, we probed
several titin-binding proteins, focusing on titin’s N2A region.
Two of these proteins, CAPN3 and MARP1 (Figure 5A), were
differentially upregulated in the two mouse models with al-
tered titin stiffness, suggesting that they might play a central
role. Normally, MARP1 is expressed at low-to-undetectable
levels in skeletal muscle,47 but during UDD the levels massively
increase (385-fold, Figure 5A). This upregulation was exagger-
ated in the RBM20ΔRRM model (1.9 ± 0.2 fold) and attenuated
in the TtnΔIAjxn model (0.9 ± 0.1 fold; relative to wildtype
upregulation) (Figure 5A). MARP1 binds to titin’s elastic N2A
region (Figure 6). MARP proteins have been proposed to be
stretch responsive9 and have been implicated in hypertrophy
signalling, through interaction with the Erk-GATA4 complex.48
As following UDD MARP1 shows no evidence of nuclear local-
ization (Figure 6A–F), therefore interaction with GATA4 is un-
likely. However, by binding to titin’s N2A region (Figure 6G–P),
MARP1 might increase titin-based stiffness, cross-link titin
ﬁlaments12,49 to sterically hinder signalling, or even form a
scaffold for other binding proteins to facilitate N2A-based
hypertrophy signalling. Binding of MARP1 to titin’s N2A seg-
ment might be facilitated by the differential upregulation of
CAPN3, which in its active state (autolytic fragments) is capable
of cleaving MARP1, thereby increasing its binding afﬁnity to
titin N2A.9 Thus, titin stiffness modulates muscle trophicity,
and we propose hypertrophy signalling intimately involves
titin’s I-band region and its binding partners (Figure 7).
Conclusions
In conclusion, the ﬁndings of the present study establish
that titin-based mechanosensing modulates muscle hyper-
trophy. Cyclic, passive muscle stretch induces diaphragm
hypertrophy, both longitudinally and cross-sectionally, and is
Figure 7 Titin-based mechanosensing model for muscle trophicity,
wherein hypertrophy signalling is induced by muscle stretch and regu-
lated through titin-binding proteins in the I-band region. TK denotes ki-
nase-domain.
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dependent on titin stiffness. Cyclic stretch of skeletal muscle
to long sarcomere lengths (as occurred during UDD) may not
occur during daily-life activities. However, it is likely that the
increase in titin-based passive tension that is associated with
the normal operating sarcomere length range in contracting
muscle (with sarcomere length changes from 2.2–2.9 μm in
the murine diaphragm (current study) and in human skeletal
muscle from ~2.8 to 3.4 μm50,51 is sufﬁcient to activate
mechanosensing activity. Furthermore, a similar mechanism
might be activated in peripheral muscle where passive stretch
is often induced by activated antagonist muscles. Finally, from
a clinical perspective, passive muscle stretch might prove an
applicable therapeutic strategy during conditions associated
with rapid decrease of muscle mass. For example, to combat
ICU-acquired muscle weakness which develops in critically ill
patients following long periods of muscle inactivity.52 Indeed,
studies in large animal models suggest that passive muscle
stretch spares muscle mass during inactivity.53
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Figure S1. Comparison of dynamic vs. static stretch protocols
for passive tension determination in permeabilized dia-
phragm ﬁbres. (A) Left: Stepwise increase in ﬁbre length.
Right: Fibre length change corresponding to the in vivo dia-
phragm kinetics and sarcomere length changes during UDD
as determined by echomyography. (B) The corresponding
changes in sarcomere length in the ﬁbres. (C) The corre-
sponding passive force. (D) Plateau forces from the static pro-
tocol (C; left) are lower than forces at the same sarcomere
length during the stretch-release protocol (C; right), highlight-
ing the importance of in vivo stretch speed in passive tension
development.
Figure S2. Whole body plethysmography in the titin models.
Respiration frequency (A), tidal volume (B), and (C) minute
volume during UDD were not affected by the genotype of
the mice. Graphs represent mean ± SEM.
Figure S3. Tissue mass changes of the whole diaphragm and
various regions of the diaphragm (excluding the right costal)
after UDD. (A) Whole diaphragm tissue mass (TM; normalized
to tibia length (TL)) is increased after UDD in all genotypes,
which reﬂects the increase in mass of the denervated right
costal (Figure 1b). (B) The innervated left costal and right crus
(C) do not hypertrophy after UDD. (D) The mass of the left
(innervated) crus increases in WT and in TtnΔIAjxn mice after
UDD. Graphs represent mean ± SEM.
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